Global Ivermectin Expert Opens up Q&A on the Antiparasitic Drug & COVID-19

Global Ivermectin Expert Opens up Q&A on the Antiparasitic Drug & COVID-19

World renowned Ivermectin researcher Carlos Chaccour, PhD, recently published on the IS Global website “Questions and Answers about Ivermectin and COVID-19.” The Assistant Research Professor, BOHEMIA Chief Scientific Officer for Barcelona Institute of Global Health (ISGlobal) has consistently advocated for rigorous scientific research during this COVID-19 pandemic. Moreover, he has collaborated with colleagues to launch clinical studies to help health providers better understand, through evidence, the potential efficacy of ivermectin. An outspoken defender of science and rigorous, evidenced-based medicine, Dr. Chaccour in interviews with TrialSite doesn’t budge in his steadfast commitment and dedication to scientifically investigating whether ivermectin is effective or not in treating COVID-19.

During this pandemic, Dr. Chaccour has received pressure from all sides, whether it be the “pro” ivermectin advocates to those that argue emergency conditions merit a loosening of standards. Dr. Chaccour is truly committed to public health for those especially in low-to-middle income countries (LMICs) and that commitment is grounded in a deep and enduring scientific practice, which ultim...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee